GHK-Cu
Status unknownAlso known as: Copper tripeptide, HY-P0063, EX-A13486, CS-0015088, Gly-His-Lys-Cu(II), Copper Peptide(GHK-Cu)
GHK-Cu (Copper tripeptide, HY-P0063, EX-A13486) is classified under copper & cosmetic signal peptides.
What the research says
Aggregated from the cited literature below. We summarize sources — we don't author claims.
GHK-Cu (copper tripeptide; Gly-His-Lys-Cu(II)) is the Cu(II) chelate/complex of the tripeptide GHK (glycyl-L-histidyl-L-lysine). Reviews of therapeutic peptides in orthopaedics note that GHK-Cu has shown promise in wound healing and anti-inflammatory effects, while also stating that no clinical data support its use for musculoskeletal conditions. Additional reviews describe GHK (and formation of GHK-Cu) as a molecule with tissue-repair and anti-inflammatory/tissue-remodeling properties, with most cited evidence focused on preclinical and in vitro contexts and with limited clinical data for GHK-Cu specifically in the skin/cosmetic area.
Mechanism (as reported)
Mechanistic claims in the provided sources describe GHK-Cu/GHK as involving copper binding/chelation and regulation of biological pathways linked to tissue remodeling and inflammation resolution. One review states that GHK forms a chelate with copper and that the peptide and its Cu(II) chelate have anti-inflammatory and tissue remodeling properties (PMIDs: 35083444). Another source states GHK can stimulate processes related to tissue repair (e.g., collagen/elastin/glycosaminoglycan synthesis and dermal fibroblast function) and describes anti-inflammatory and cell-protective actions attributed to GHK’s diverse biological activities (PMIDs: 29986520). A skin-regeneration focused review further describes copper-complex-related wound-healing/skin repair proposals, modulation of collagen and glycosaminoglycan synthesis and metalloproteinase systems (PMIDs: 26236730).
Key findings (each cites a source)
- Narrative review of injectable peptide therapy in orthopaedics reported that GHK-Cu showed promise in wound healing and anti-inflammatory effects, but noted that no clinical data support its use for musculoskeletal conditions. [PMID 41476424]
- Orthopaedic therapeutic-peptide review described wound-healing peptides, including GHK-Cu, as promoting angiogenesis and integrin-mediated extracellular matrix remodeling and fibroblast activation, while also stating there is a current lack of clinical trials. [PMID 41490200]
- Review research reported that GHK (and its Cu(II) chelate formation) is associated with anti-inflammatory and tissue remodeling properties, including reported skin remodeling and wound healing/regeneration plus antioxidant and anti-inflammatory effects in in vitro and in vivo studies. [PMID 35083444]
- Review research described GHK’s biological actions as including stimulation of blood vessel and nerve outgrowth and increased collagen/elastin/glycosaminoglycan synthesis, and also described anti-inflammatory/cell-protective actions attributed to GHK. [PMID 29986520]
- Skin-regeneration-focused review stated that GHK is proposed to function as a complex with copper 2+ that accelerates wound healing and skin repair, including effects on collagen and glycosaminoglycan synthesis and modulation of metalloproteinases and their inhibitors. [PMID 26236730]
- Anti-wrinkle/cosmetic-focused review reported that GHK-Cu and Pal-GHK are metal complex derivatives used in cosmetic market products but found that published information and clinical studies using GHK-Cu were lacking; it also summarized that cell studies support GHK as an anti-wrinkle ingredient and discussed formulation/permeation enhancement issues. [PMID 39963574]
- Liposome-carrier research reported preparation of GHK-Cu-loaded liposomes (about 100 nm) and in vitro assays, including elastase inhibition and tyrosinase-related findings (that GHK-Cu did not significantly affect tyrosinase activity in that study), concluding the liposomes can be used as carriers and reporting elastase inhibition that supports reduced elastin degeneration rate in the context of the assay. [PMID 37896245]
- Coordination-chemistry research reported that GHK and cis-urocanic acid can both coordinate Cu(II) and that a ternary Cu(II) complex species [GHK][Cu(II)][cis-urocanic acid] may be partly responsible for biological effects attributed to GHK and urocanic acid described in the literature. [PMID 32867146]
Independent test grades (67 vendors)
Aggregated from Finnrick (independent testing). Their grades, attributed — not our verdict.
| Vendor | Grade | Score |
|---|---|---|
| Nanjing Xiyuxun Technology | X Unrated | — |
| Planet Peptide | X Unrated | — |
| Wuhan Newtop Biotech | X Unrated | — |
| Pharma Grade Peptides | A Great | 10.0 |
| Bulk Peptide Wholesale | A Great | 9.2 |
| Atomik Labz | A Great | 8.7 |
| Yabang Peptide | A Great | 8.5 |
| Orbitrex Peptides | A Great | 8.5 |
| Shanghai Baoju | A Great | 8.4 |
| Coffee and Peppers | A Great | 8.2 |
| SubQ Society | A Great | 8.2 |
| Yiwu Aozuo Trading Co | C Okay | 8.1 |
| Peptide Sciences | B Good | 8.1 |
| Precision Peptide Co | A Great | 8.0 |
| Aminos Research | A Great | 8.0 |
| Polaris Peptides | A Great | 8.0 |
| Anlv Biotechnology | A Great | 8.0 |
| Qing Li Peptide | C Okay | 7.9 |
| Peptide-S | Okay | 7.8 |
| Reta-Peptide | D Poor | 7.8 |
| Zen Peptides | B Good | 7.7 |
| Nexaph | C Okay | 7.6 |
| Wuhan Wansheng Biotechnology | F Fraud | 7.6 |
| Xingruida XDR | C Okay | 7.5 |
| Heman Peptide HM | C Okay | 7.5 |
Research literature (8)
Consolidated from PubMed — each links to the original record.
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
Mayfield CK, Bolia IK, Feingold CL, Lin EH, Liu JN, Rick Hatch GF · The American journal of sports medicine · 2026 · PMID 41476424
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Rahman OF, Lee SJ, Seeds WA · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026 · PMID 41490200
- Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.
Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR · BioImpacts : BI · 2025 · PMID 39963574
- Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application.
Dymek M, Olechowska K, Hąc-Wydro K, Sikora E · Pharmaceutics · 2023 · PMID 37896245
- The potential of GHK as an anti-aging peptide.
Dou Y, Lee A, Zhu L, Morton J, Ladiges W · Aging pathobiology and therapeutics · 2020 · PMID 35083444
- Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate.
Bossak-Ahmad K, Wiśniewska MD, Bal W, Drew SC, Frączyk T · International journal of molecular sciences · 2020 · PMID 32867146
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.
Pickart L, Margolina A · International journal of molecular sciences · 2018 · PMID 29986520
- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.
Pickart L, Vasquez-Soltero JM, Margolina A · BioMed research international · 2015 · PMID 26236730
FAQ
- What is GHK-Cu?
- GHK-Cu (Copper tripeptide, HY-P0063, EX-A13486) is classified under copper & cosmetic signal peptides. Research goals associated with it include recovery & tissue repair, skin, hair & pigmentation.
- Is GHK-Cu FDA-approved?
- The regulatory status of GHK-Cu is not established in our sources.
- What does the research on GHK-Cu say?
- peptideone aggregates 8 references from PubMed for GHK-Cu. The summary on this page digests them with citations; we summarize sources and make no efficacy claims.